| Literature DB >> 6393400 |
C A Hubay, B Arafah, N H Gordon, S P Guyton, J P Crowe.
Abstract
The introduction of measurements of hormone receptors in breast cancer tumor specimens provides a major advance in selection of patients likely to have hormone-dependent cancers. Endocrine adjuvant treatment for estrogen-positive breast cancers in both pre- and postmenopausal women has been shown to be effective in delaying recurrence. Whenever possible, estrogen and progesterone receptors should be measured in tumor tissue from all patients with breast cancer.Entities:
Mesh:
Substances:
Year: 1984 PMID: 6393400 DOI: 10.1016/s0039-6109(16)43487-0
Source DB: PubMed Journal: Surg Clin North Am ISSN: 0039-6109 Impact factor: 2.741